Gefitinib plus clocetaxel in non-small-cell lung cancer

被引：2
|
作者：
Zalcman, Gerard [1 ,2 ]
Bergot, Emmanuel [1 ,2 ]
机构：
[1] CHU Caen, Chest Dept, F-14033 Caen 05, France
[2] CHU Caen, ER3, INSERM, F-14033 Caen 05, France
来源：
LANCET | 2009年 / 373卷 / 9663期
关键词：
D O I：
10.1016/S0140-6736(09)60192-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：541 / 541
页数：1
相关论文
共 50 条
  • [31] Histoculture drug response assay for gefitinib in non-small-cell lung cancer
    Yoshimasu T.
    Ohta F.
    Oura S.
    Tamaki T.
    Shimizu Y.
    Naito K.
    Kiyoi M.
    Hirai Y.
    Kawago M.
    Okamura Y.
    General Thoracic and Cardiovascular Surgery, 2009, 57 (3) : 138 - 143
  • [32] A CASE OF ERYSIPELAS IN A NON-SMALL-CELL LUNG CANCER PATIENT RECEIVING GEFITINIB
    Kita, T.
    Nishijima, C.
    Inaoki, M.
    Kasahara, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 146 - 147
  • [33] Comparison of Gefitinib and Erlotinib for Patients with Advanced Non-Small-Cell Lung Cancer
    Lee, Jin Hwa
    Lee, Kyoung Eun
    Ryu, Yon Ju
    Chun, Eun Mi
    Chang, Jung Hyun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 66 (04) : 280 - 287
  • [34] Erlotinib in advanced non-small-cell lung cancer after gefitinib failure
    Zhou, Zheng-Tao
    Xu, Xin-Hua
    Wei, Qing
    Lu, Ming-qian
    Wang, Jie
    Wen, Cai-Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (06) : 1123 - 1127
  • [35] Practical management of patients with non-small-cell lung cancer treated with gefitinib
    Shah, NT
    Kris, MG
    Pao, W
    Tyson, LB
    Pizzo, BM
    Heinemann, MH
    Ben-Porat, L
    Sachs, DL
    Heelan, RT
    Miller, VA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) : 165 - 174
  • [36] Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
    Maemondo, Makoto
    Inoue, Akira
    Kobayashi, Kunihiko
    Sugawara, Shunichi
    Oizumi, Satoshi
    Isobe, Hiroshi
    Gemma, Akihiko
    Harada, Masao
    Yoshizawa, Hirohisa
    Kinoshita, Ichiro
    Fujita, Yuka
    Okinaga, Shoji
    Hirano, Haruto
    Yoshimori, Kozo
    Harada, Toshiyuki
    Ogura, Takashi
    Ando, Masahiro
    Miyazawa, Hitoshi
    Tanaka, Tomoaki
    Saijo, Yasuo
    Hagiwara, Koichi
    Morita, Satoshi
    Nukiwa, Toshihiro
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (25): : 2380 - 2388
  • [37] Pulmonary Toxicities of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer
    Hong, Dongsheng
    Zhang, Guobing
    Zhang, Xingguo
    Lian, Xingguang
    MEDICINE, 2016, 95 (09)
  • [38] Gefitinib in pretreated advanced or metastatic non-small-cell lung cancer patients
    Garde, J
    Blasco, A
    Camps, C
    Juarez, A
    Caballero, C
    Sirera, R
    Bayo, R
    Ponce, R
    Berrocal, A
    Jackobs, J
    LUNG CANCER, 2004, 45 : S80 - S80
  • [39] Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer
    Passaro, Antonio
    Alesini, Daniele
    Pochesci, Alessia
    Cortesi, Enrico
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (05) : 646 - 650
  • [40] Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib
    Sakai M.
    Ishikawa S.
    Ito H.
    Ozawa Y.
    Yamamoto T.
    Onizuka M.
    Sakakibara Y.
    International Journal of Clinical Oncology, 2006, 11 (3) : 243 - 245
12345